慢性乙型肝炎患者外周血细胞毒T细胞表面NK相关受体的表达

doi:10.3969/j.issn.1673-8640.2017.02.009

摘要/Abstract

摘要：

目的探讨慢性乙型肝炎（CHB）患者细胞毒T细胞（CTL）表面NK相关受体（NKR）的变化格局,了解CHB患者CTL对乙型肝炎病毒（HBV）免疫应答的受体途径。方法用流式细胞术分析40例CHB患者（HBV DNA阳性18例,HBV DNA阴性22例）和20名健康对照者（正常对照组）外周血CTL百分率及其表面NK相关的激活性受体NKG2D和NKp30以及抑制性受体NKG2A和KIR2DL3的表达水平,统计分析2组间上述指标的差异及其与HBV DNA载量、HBV感染血清标志物和肝脏损伤标志物等的相关性。结果 CHB组外周血T细胞中CTL百分率[（19.33±6.25）%]显著低于正常对照组[（23.94±6.09）%]（P<0.05）,CTL表面表达KIR2DL3的细胞比例[（3.32±2.63）%]显著高于正常对照组[（1.55±0.53）%]（P<0.05）。CHB患者中HBV DNA阳性组外周血CTL百分率[（16.94±4.8）%]显著低于HBV DNA阴性组[（21.29±6.7）%]（P<0.05）;HBV DNA阳性组CTL表面表达KIR2DL3的细胞比例[（3.85±3.41）%]显著高于HBV DNA阴性组[（2.91±1.81）%]（P<0.05）。相关性分析结果显示,CHB患者外周血中表达NKG2A的CTL比例与血清HBV DNA和丙氨酸氨基转移酶（ALT）水平呈显著正相关（r值分别为0.580、0.671,P<0.01）,CHB患者外周血中表达KIR2DL3的CTL比例与HBeAg呈显著正相关（r=0.556,P<0.001）。结论 CHB患者存在CTL数量和功能的缺失,即T细胞耗竭;CHB患者CTL上NK相关抑制性和激活性受体表达格局的变化致使CTL活性受损和免疫应答紊乱,导致HBV不能得到有效清除,引起肝细胞损伤。CTL上NK相关抑制性受体表达水平可望成为CHB病情评估的新指标以及CHB治疗的潜在新靶点。

关键词: NK相关受体, 慢性乙型肝炎, 细胞毒T细胞

Abstract:

Objective To investigate the change patterns of natural killer（NK）-associated receptors（NKR） on cytotoxic T lymphocyte（CTL）from peripheral blood of patients with chronic hepatitis B（CHB）,and to study the receptor pathway of CTL from CHB patients responding to hepatitis B virus（HBV）.Methods The percentages of CTL and the expressions of NK-associated activating receptors（NKG2D and NKp30） and NK-associated inhibitory receptors（NKG2A and KIR2DL3） on CTL were determined by flow cytometry in 40 patients with CHB（18 cases of HBV DNA positive and 22 cases of HBV DNA negative） and 20 healthy controls. The difference between the 2 groups and the correlations with HBV DNA load,HBV infection serology markers and liver injury markers and so on were analyzed.Results The percentage of CTL in T cells from peripheral blood in CHB group [（19.33±6.25）%] was lower than that of healthy control group[（23.94±6.09）%]（P<0.05）. The proportion of CTL expressing KIR2DL3 in CHB group [（3.32±2.63）%] was higher than that in healthy control group [（1.55±0.53）%]（P<0.05）. The percentage of CTL in HBV DNA positive CHB group [（16.94±4.8）%] was lower than that in HBV DNA negative CHB group[（21.29±6.7）%]（P<0.05）,and the proportion of CTL expressing KIR2DL3 in HBV DNA positive CHB group[（3.85±3.41）%] was higher than that in HBV DNA negative CHB group[（2.91±1.81）%]（P<0.05）. The proportion of CTL expressing NKG2A was positively correlated with HBV DNA load and alanine aminotransferase（ALT） level in CHB group （r=0.580 and 0.671,P<0.01）,and the proportion of CTL expressing KIR2DL3 was positively correlated with hepatitis B e antigen（HBeAg）（r=0.556,P<0.001）. Conclusions There is a defect in quantity and function of CTL in CHB patients,which means T cell exhaustion. The change pattern of NK-associated inhibitory receptors and activating receptors on CTL from CHB patients impairs the activation of CTL and immune response disorders,which results that HBV can not be effectively cleared,and hepatic cells are injured. The expression levels of NK-associated inhibitory receptors on CTL are expected to develop into a new indicator to evaluate the disease severity and the potential targets of therapy for CHB.

Key words: Natural killer-associated receptor, Chronic hepatitis B, Cytotoxic T lymphocyte

中图分类号:

R446.1

葛丹红, 徐翀, 姚玉峰. 慢性乙型肝炎患者外周血细胞毒T细胞表面NK相关受体的表达[J]. 检验医学, 2017, 32(2): 108-113.

GE Danhong, XU Chong, YAO Yufeng. Expressions of natural killer-associated receptors on cytotoxic T lymphocyte from peripheral blood of patients with chronic hepatitis B[J]. Laboratory Medicine, 2017, 32(2): 108-113.

图/表 7

图1 CHB患者和正常对照者外周血T淋巴细胞中CTL的百分率

图2 CHB患者和正常对照者外周血CTL中表达KIR2DL3的细胞比例

图3 CHB组和正常对照组外周血CTL中表达NKR的比例比较

图4 HBV DNA阳性者和HBV DNA阴性者外周血CTL中表达KIR2DL3的细胞比例

图5 CHB患者外周血中表达NKG2A 的CTL比例与HBV DNA的相关性

图6 CHB患者外周血中表达NKG2A 的CTL比例与ALT的相关性

图7 CHB患者外周血中表达KIR2DL3的CTL比例与HBeAg的相关性

参考文献 10

[1]	.中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版)[J]. 中华实验和临床感染病杂志(电子版),2015,9(5):570-589.
[2]	.YE B,LIU X,LI X,et al.T-cell exhaustion in chronic hepatitis B infection:current knowledge and clinical significance[J]. Cell Death Dis,2015,6:e1694.
[3]	.ZUNIGA E I,MACAL M,LEWIS G M,et al.Innate and adaptive immune regulation during chronic viral infections[J]. Annu Rev Virol,2015,2(1):573-597.
[4]	.TIAN X,ZHANG A,QIU C,et al.The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects[J]. J Immunol,2015,194(8):3873-3882.
[5]	.BUI J K,MELLORS J W.Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1[J]. AIDS,2015, 29(15):1911-1915.
[6]	.TAVENIER J,LANGKILDE A,HAUPT T H,et al.Immunosenescence of the CD8(+)T cell compartment is associated with HIV-infection,but only weakly reflects age-related processes of adipose tissue,metabolism,and muscle in antiretroviral therapy-treated HIV-infected patients and controls[J]. BMC Immunol,2015,16:72.
[7]	.周光炎. 免疫学原理[M]. 2版. 上海:上海科学技术出版社,2007:45.
[8]	.LI Q,SKINNER P J,HA S J,et al.Visualizing antigen-specific and infected cells in situ predicts overcomes in early viral infection[J]. Science,2009,323(5922):1726-1729.
[9]	.BLACKBURN S D,SHIN H,HAINING W N,et al.Coregulation of CD8+T cells exhaustion by multiple inhibitory receptors during chronic viral infection[J]. Nat Immunol,2009,10(1):29-37.
[10]	.MUELLER S N,AHMED R.High antigen levels are the cause of T cell exhaustion during chronic viral infection[J]. Proc Natl Acad Sci U S A,2009,106(21):8623-8628.

[1]	刘洋, 耿坤静, 栗红江, 石昊曦, 陈思思. 25（OH）D₃与肝脏炎症分期和抗病毒疗效的相关性分析[J]. 检验医学, 2022, 37(7): 628-631.
[2]	马艳婷, 苏曦, 黄斐, 王梦娴, 沈敏娜, 张春燕, 王蓓丽, 潘柏申, 郭玮. HBV RNA检测在慢性乙型肝炎中的临床价值[J]. 检验医学, 2022, 37(1): 72-77.
[3]	李彩东, 张旭强, 雷志萍, 陈俏丽, 陈璐, 田鹏飞, 段正军. IL-1β、IL-6、TNF-α在慢性HBV感染不同临床病程中的临床意义[J]. 检验医学, 2021, 36(8): 790-794.
[4]	程惠芬. 血清P-选择素、ICAM-1、IL-17A水平在HBV感染相关疾病中的临床价值[J]. 检验医学, 2021, 36(6): 646-649.
[5]	刘婷婷, 林玉婷, 米拉, 李晓勤. 血清IL-33水平及其基因多态性与HBV感染临床转归的相关性[J]. 检验医学, 2021, 36(11): 1101-1105.
[6]	郭平, 庄丽花, 陈骊婷, 王剑飚, 吴建峰. 平均红细胞体积、红细胞分布宽度和血清淀粉样蛋白A监测慢性乙型肝炎进展的价值初探[J]. 检验医学, 2020, 35(11): 1153-1157.
[7]	王颖智, 刘华, 王文涓, 高锋, 杨翠霞. CHB患者血清miRNA-122和miRNA-155检测的价值[J]. 检验医学, 2019, 34(8): 691-695.
[8]	俞晓春, 胡旭姣, 章家青, 国蕾蕾. HA、Ⅳ-C、APRI及Fib-4对乙型肝炎后肝纤维化的诊断效果[J]. 检验医学, 2019, 34(6): 539-542.
[9]	高万芹, 张勤, 朱琳, 吴斌, 何文涛, 张庭禄, 赵长新. 慢性乙型肝炎患者HBV基因型分析及对6种核苷类药物的耐药性[J]. 检验医学, 2019, 34(11): 994-997.
[10]	郭静, 李从荣. 慢性乙型肝炎患者HBV DNA载量与血小板及APRI的相关研究[J]. 检验医学, 2018, 33(4): 321-323.
[11]	侯丽, 于璐, 牛瑶, 张媛, 王亮. 非创伤性诊断模型在慢性乙型肝炎患者肝纤维化中的应用[J]. 检验医学, 2018, 33(10): 888-893.
[12]	梁冬雨, 侯彦强, 娄晓丽. HBV相关肝炎、肝硬化及肝癌患者DcR3的表达及其与Fas的关系[J]. 检验医学, 2017, 32(3): 178-181.
[13]	冯玥玥, 王蕾. 慢性乙型肝炎患者中医辨证与实验室指标相关性的研究进展[J]. 检验医学, 2016, 31(2): 147-152.
[14]	杜振华, 鲍布和, 王仁杰, 任党利, 张明华, 刘冀琴. 外周血DNT细胞及T细胞亚群变化与乙型肝炎慢性化的相关性研究[J]. 检验医学, 2015, 30(7): 723-727.
[15]	刘伟平, 易琴, 殷明刚. ALT和HBV DNA联合诊断e抗原阴性的慢性活动性乙型肝炎诊断界值的建立及评价[J]. 检验医学, 2014, 29(5): 483-487.